How Recent Developments Are Rewriting the Story for Cryoport and Its Valuation Outlook
AI Sentiment
Positive
7/10
as of 12-12-2025 3:58pm EST
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 438.7M | IPO Year: | N/A |
| Target Price: | $12.83 | AVG Volume (30 days): | 594.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.27 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.58 - $11.44 | Next Earning Date: | 11-04-2025 |
| Revenue: | $243,795,000 | Revenue Growth: | 41.27% |
| Revenue Growth (this year): | -22.8% | Revenue Growth (next year): | 9.26% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
CYRX Breaking Stock News: Dive into CYRX Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
7/10
See how CYRX stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "CYRX CryoPort Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.